Dr. Mark Nicolls

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Mark Nicolls. Improve your application with a focused, well-structured draft.

Biography

Mark Nicolls specializes in the treatment of lung transplant patients and has practiced pulmonary critical care medicine for over 20 years. His special interests include the immune system's contribution to vascular disease, focusing on basic science laboratory work related to lung transplantation and pulmonary hypertension. His research group incorporates the study of embryologic lung development to help explain adult pulmonary diseases. Nicolls has held several administrative appointments, including Director of Lung Immunology and Chief of Pulmonary, Allergy and Critical Care Medicine. He has contributed significantly to the field through research, clinical trials, and numerous patents, particularly in immunology, pulmonary hypertension, and lymphedema. Mark is actively involved in the academic community as a member of various committees and was recognized as an elected member of the American Society for Clinical Investigation and the Association of American Physicians. He serves as a Professor at Stanford University and is committed to advancing medical research and education in pulmonary critical care medicine.

Research Interests

Experience

Director of Lung Immunology

2007-01-01 — Present

Stanford University • Stanford, CA

Oversees research and clinical initiatives in the domain of lung immunology.

Chief of Pulmonary, Allergy Critical Care Medicine

2010-01-01 — Present

Stanford Health Care • Stanford, CA

Leads the administrative and clinical operations of the pulmonary, allergy, and critical care medicine unit.

Patents

HIF-1 modulator paint formation uses thereof

10548860 2020-02-04

Patent for a novel paint formulation that modulates HIF-1.

Nanogrid electrochemical sensor detection biochemical species

10527577 2020-01-07

Patent related to a sensor technology for detecting biochemical species.

LTB4 inhibition prevent treat lymphedema

10500178 2019-12-10

Patent addressing the treatment of lymphedema.

HIF-1 Modulator Paint Formulation Uses Thereof

10,220,009 2019-03-05

Patent regarding another formulation modulating HIF-1.

Treatment pulmonary arterial hypertension leukotriene inhibitors

9861601 2018-01-09

Patent concerning the treatment of pulmonary arterial hypertension.

Methods improving microvascular integrity

9682071 2017-06-20

Patent outlining methods for enhancing microvascular integrity.

Treatment pulmonary hypertension leukotriene inhibitors

9233089 2016-01-12

Another patent related to leukotriene inhibitors for pulmonary hypertension.

Courses

IMMUNOL 299 MED 299 IMMUNOL 280 MED 280 IMMUNOL 399 MED 399 MED 370 IMMUNOL 290 IMMUNOL 199 MED 199

Requirements for Stanford University

Doctorate Program
Requirements
GPA Requirement
Required:3.5
TOEFL
Listening
Required:26
Reading
Required:26
Writing
Required:26
Speaking
Required:26
Total
Required:100
GRE General
Verbal
Required:160
Quantitative
Required:165
Analytical Writing
Required:4.5
Overall
Required:4.5
Prerequisites
Bachelor degree from an accredited institution Strong background in mathematics and programming
Application Checklist
  • Statement of Purpose
  • Three letters of recommendation
  • Official transcripts
  • Resume/CV
Specialization Notes

The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.